Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
Bepirovirsen (GSK3228836) in chronic hepatitis B infection: an evaluation of phase II progress Journal:Expert Opinion on Investigational Drugs | 30-Oct-2023 | ||
FAT4 loss initiates hepatocarcinogenesis through the switching of canonical to noncanonical WNT signaling pathways Journal:Hepatology Communications | 7-Dec-2023 | ||
3-Apr-2024 |